Copper oxide nanoparticles: from EU-regulatory landscape and mechanistic toxicity towards a cuproptosis-linked adverse outcome pathway - Quiz - MDSpire

Copper oxide nanoparticles: from EU-regulatory landscape and mechanistic toxicity towards a cuproptosis-linked adverse outcome pathway

  • By

  • Sophie Scholz

  • Julia Prinz

  • Linde Sevenants

  • Andrea Holzwarth

  • Birgit Mertens

  • Robert Pieper

  • Vera Ritz

  • Kirsten Schulz

  • Holger Sieg

  • Aswin Mangerich

  • Linda Böhmert

  • June 27, 2026

  • 0 min

Share

Original Source(s)

Copper oxide nanoparticles: from EU-regulatory landscape and mechanistic toxicity towards a cuproptosis-linked adverse outcome pathway

  • by Sophie Scholz, Julia Prinz, Linde Sevenants, Andrea Holzwarth, Birgit Mertens, Robert Pieper, Vera Ritz, Kirsten Schulz, Holger Sieg, Aswin Mangerich, Linda Böhmert

  • June 27, 2026

Related Content

Case Report: Primary epithelioid sarcoma of orbit: first case in Asia and literature review

Can Labs Go Green Without Compromising Science?

Industry experts discuss how labs, suppliers, and logistics can work together to reduce diagnostics' carbon footprint

Immunoinformatics-driven design of a multi-epitope vaccine against Clostridium perfringens in yaks